Vitamin A

How to get vaccines to remote areas? In Sierra Leone they’re delivered by foot, boat or motorbike

Retrieved on: 
Thursday, April 18, 2024

In Sierra Leone almost 59% of the population live in remote, rural areas.

Key Points: 
  • In Sierra Leone almost 59% of the population live in remote, rural areas.
  • Roads may be non-existent or in bad condition, making it very difficult for rural dwellers to access healthcare.

Why are vaccination rates low in Sierra Leone?

  • In stark contrast, only 15% of people had been vaccinated in low-income countries.
  • The hardships Sierra Leoneans face are typical of the obstacles people in low-income countries have to overcome to access healthcare.
  • In the early days of the COVID-19 vaccination campaign in Sierra Leone, it took the average Sierra Leonean living in a rural community three-and-a-half hours each way to the nearest vaccination centre.

How did this vaccine drive tackle the problem?

  • The primary aim of this intervention was to take vaccine doses and nurses to administer vaccines to remote, rural communities, preceded by seeking permission and community mobilisation.
  • At the time, only 6% to 9% of the adults who took part in the programme were already immunised.
  • The leaders were asked for their cooperation in encouraging eligible community members to take the COVID-19 vaccine.
  • Finally, vaccine doses and healthcare workers arrived at the villages to administer the doses.

Looking forward

  • This approach proved 76% more cost-effective than other vaccination campaigns.
  • Transport accounted for a large share of the costs, so the cost-effectiveness of last mile delivery can be increased by offering a “bundle” of health products.
  • Other estimates put the death toll for the same period at 14.83 million, which is 2.74 times higher.
  • Developing cost-effective strategies to make vaccines easily accessible to everyone, everywhere, is the most promising solution to prevent future pandemics.


Niccolò Francesco Meriggi receives funding from Weiss Asset Management, UKRI and the International Growth Centre.

Ready to Drink Beauty Beverage Market to Reach US$ 4,428.5 Million by 2034 Amid Growing Focus on Convenience and On-the-go Consumption

Retrieved on: 
Tuesday, April 9, 2024

NEWARK, Del., April 9, 2024 /PRNewswire/ -- According to Future Market Insights (FMI), the worldwide ready-to-drink beauty beverage market is valued at US$ 1,956.9 million in 2024 and is anticipated to reach US$ 4,428.5 million by 2034. Over the next decade, global ready to drink beauty beverages demand is likely to increase at a CAGR of 8.5%.

Key Points: 
  • NEWARK, Del., April 9, 2024 /PRNewswire/ -- According to Future Market Insights (FMI), the worldwide ready-to-drink beauty beverage market is valued at US$ 1,956.9 million in 2024 and is anticipated to reach US$ 4,428.5 million by 2034.
  • Over the next decade, global ready to drink beauty beverages demand is likely to increase at a CAGR of 8.5%.
  • Key Takeaways from the Ready to Drink Beauty Beverages Report:
    The global ready-to-drink beauty beverage market is expected to reach a valuation of US$ 4,428.5 million by 2034.
  • "The ready-to-drink beauty beverage market is experiencing growth due to health-conscious consumers seeking convenient and on-the-go beauty solutions.

Ready to Drink Beauty Beverage Market to Reach US$ 4,428.5 Million by 2034 Amid Growing Focus on Convenience and On-the-go Consumption

Retrieved on: 
Tuesday, April 9, 2024

NEWARK, Del., April 9, 2024 /PRNewswire/ -- According to Future Market Insights (FMI), the worldwide ready-to-drink beauty beverage market is valued at US$ 1,956.9 million in 2024 and is anticipated to reach US$ 4,428.5 million by 2034. Over the next decade, global ready to drink beauty beverages demand is likely to increase at a CAGR of 8.5%.

Key Points: 
  • NEWARK, Del., April 9, 2024 /PRNewswire/ -- According to Future Market Insights (FMI), the worldwide ready-to-drink beauty beverage market is valued at US$ 1,956.9 million in 2024 and is anticipated to reach US$ 4,428.5 million by 2034.
  • Over the next decade, global ready to drink beauty beverages demand is likely to increase at a CAGR of 8.5%.
  • Key Takeaways from the Ready to Drink Beauty Beverages Report:
    The global ready-to-drink beauty beverage market is expected to reach a valuation of US$ 4,428.5 million by 2034.
  • "The ready-to-drink beauty beverage market is experiencing growth due to health-conscious consumers seeking convenient and on-the-go beauty solutions.

Belite Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

Retrieved on: 
Tuesday, March 12, 2024

ET

Key Points: 
  • ET
    SAN DIEGO, March 11, 2024 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio” or the “Company”), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced its audited financial results for full-year 2023 and the unaudited and unreviewed financial results for the quarter ended December 31, 2023, and provided a business update.
  • The decrease resulted primarily from higher R&D expenses in the fourth quarter of 2022 as the DRAGON trial reached certain milestones in such quarter.
  • Belite Bio will host a webcast on Tuesday, March 12, 2023, at 4:30 p.m. Eastern Time to discuss the Company’s financial results and provide a business update.
  • A replay will be available for approximately 90 days following the event at the Company’s Investor Relations website at https://investors.belitebio.com/presentations-events/events .

Global Vitamin A Market Analysis, Size, Trends and Forecasts to 2029 - A US$745.84 Million Market by 2029, with Expected CAGR of 5.26% Over 2024-2029 - ResearchAndMarkets.com

Retrieved on: 
Monday, April 1, 2024

The global vitamin A market value stood at US$548.36 million in 2023 and is expected to reach US$745.84 million by 2029.

Key Points: 
  • The global vitamin A market value stood at US$548.36 million in 2023 and is expected to reach US$745.84 million by 2029.
  • The market is expected to grow at a CAGR of 5.26% over the projected period of 2024-2029.
  • The rising demand for functional foods, fortified with essential nutrients including vitamin A, has also contributed to market growth.
  • Overall, Asia Pacific's dynamic market landscape positions it as a key player in the global vitamin A sector.

YourChoice Therapeutics Scientific Advisory Board member updates phase 1a study for male birth control candidate at ACS Spring 24

Retrieved on: 
Tuesday, March 19, 2024

YourChoice Therapeutics, a San Francisco biotech startup developing the first hormone-free male birth control pill, announced today that Gunda Georg, YCT-529’s co-inventor, provided an update on its phase 1a clinical study for the first hormone-free male birth control pill, YCT-529, at the American Chemical Society (ACS) 2024 Spring Meeting.

Key Points: 
  • YourChoice Therapeutics, a San Francisco biotech startup developing the first hormone-free male birth control pill, announced today that Gunda Georg, YCT-529’s co-inventor, provided an update on its phase 1a clinical study for the first hormone-free male birth control pill, YCT-529, at the American Chemical Society (ACS) 2024 Spring Meeting.
  • The phase 1a study investigates the safety, tolerability, pharmacokinetics, and pharmacodynamics of single, ascending oral doses of YCT-529 in 16 participants.
  • I’m pleased to be a part of that future.”
    YCT-529 is a hormone-free birth control candidate currently under investigation.
  • “Men and women want more birth control options, and they want them to be hormone-free,” said Akash Bakshi, co-founder and CEO of YourChoice Therapeutics.

Particles for Humanity Completes Study Confirming No Major Difference in Taste or Smell of Bouillon and Broth with PFH-VAP

Retrieved on: 
Tuesday, April 2, 2024

CAMBRIDGE, Mass., April 2, 2024 /PRNewswire/ -- Particles for Humanity has completed a study showing no major difference between the taste and smell of bouillon cubes containing the company's lead product, a stable form of vitamin A, called PFH-VAP.

Key Points: 
  • CAMBRIDGE, Mass., April 2, 2024 /PRNewswire/ -- Particles for Humanity has completed a study showing no major difference between the taste and smell of bouillon cubes containing the company's lead product, a stable form of vitamin A, called PFH-VAP.
  • One reason that food fortification is effective at addressing micronutrient deficiencies is because it does not require consumer behavior change.
  • The inclusion of PFH-VAP did not cause any major differences in taste or smell for cubes stored at either mild or harsh conditions.
  • Particles for Humanity transforms early-stage medical technology into products for people living in low and lower-middle income countries.

Innovation In Every Sip: Nokix's Quest For The Ultimate Flavor & Wellness Experience

Retrieved on: 
Friday, March 22, 2024

SACRAMENTO, Calif., March 22, 2024 /PRNewswire/ -- Nokix Sparkling Water is redefining the beverage industry with its innovative approach to crafting the ultimate flavor experience.

Key Points: 
  • SACRAMENTO, Calif., March 22, 2024 /PRNewswire/ -- Nokix Sparkling Water is redefining the beverage industry with its innovative approach to crafting the ultimate flavor experience.
  • Each sip embodies the spirit of innovation, offering a healthier, flavorful alternative in the market.
  • Experience the innovative blend of flavors and the commitment to quality with every sip of Nokix Sparkling Water.
  • Sign up for exclusive updates and be part of our journey towards launching the ultimate flavor experience at www.nokixsparkling.com .

Experts Urge Vaccination as Measles Cases Rise

Retrieved on: 
Tuesday, March 5, 2024

With measles cases on the rise, experts are urging everyone to make sure they are up to date on vaccination.

Key Points: 
  • With measles cases on the rise, experts are urging everyone to make sure they are up to date on vaccination.
  • Measles was declared eliminated in the US in 2000, but cases still occur when international travelers who get measles overseas bring it into the US or as cases spread in US communities with pockets of unvaccinated people.
  • Severe measles cases among children, including those who are hospitalized, may be treated with vitamin A, according to an NFID report on Vitamin A for the Management of Measles in the US .
  • NFID experts are available to talk about measles, the recent increase in cases in the US, the importance of measles vaccination as recommended, and treatment with vitamin A for severe cases.

NURISR Introduces New Skin Nourishing Dietary Supplement Line to Combat Acne

Retrieved on: 
Thursday, February 22, 2024

FLORIDA, Fla., Feb. 22, 2024 /PRNewswire-PRWeb/ -- NURISR, a forward-thinking health and wellness brand, is proud to announce the launch of its latest dietary supplement capsules, specifically designed to nourish the skin and support overall well-being. Building on a foundation of natural, potent ingredients, NURISR aims to offer a comprehensive solution to individuals battling acne and seeking to improve their skin health.

Key Points: 
  • Building on a foundation of natural, potent ingredients, NURISR aims to offer a comprehensive solution to individuals battling acne and seeking to improve their skin health.
  • The newly launched product line features a carefully curated selection of ingredients known for their antioxidant, anti-inflammatory, and skin health-promoting properties.
  • As NURISR continues to explore and expand its product offerings, the brand remains focused on its mission to empower individuals with effective, natural solutions for acne and skin health.
  • With the launch of this new dietary supplement line, NURISR reaffirms its commitment to helping people regain control of their skin health, offering a path to clearer, healthier skin.